Skip to main content
. 2017 Jan 27;8(9):15399–15406. doi: 10.18632/oncotarget.14853

Figure 1. NF-κB expression in human Asherman syndrome patient samples.

Figure 1

Endometrial tissues were collected from Asherman syndrome patient and control individuals for analysis of NF-κB expression by quantitative PCR (A) and IHC staining (B). In Figure A, the relative expression of NF-κB was first normalized to internal control GAPDH, then the expression of NF-κB in the IUA samples were normalized to the NF-kB level in the controls (set as 1). Arrows indicate the representative NF-κB positive cells. Scale bar = 10 uM. The intensity and percentage of positive staining signal were summarized in Figure (C) ***P < 0.001.